On the TechTO stage ×1
Next-Gen Regenerative Medicine | Drew Taylor, Co-Founder & CEO of Acorn
Watch on YouTube ↗First seen on the TechTO stage in 2019. Every talk is searchable — ask the archive about Drew ↗
In their words
one day potentially when you're older and maybe you're a doctor we're actually going to be using that patient's own cells to create them new tissues that are healthy
today there's a clinical trial ongoing using the cells that acorn takes to actually treat that same soft tissue sports injury that I have endured
tissue engineering stem cell therapies 3d bioprinting gene therapy this is the future of healthcare it's not manufacturing a chemical compound anymore it's actually using your own cells to create the next drugs
Around the web ×4
Quick answers
What does Acorn Biolabs do?
It collects live stem cells non-invasively by plucking around fifty hair follicles in a clinic, cryopreserves them, and processes banked cells into personalised treatments for skin and hair applied in a practitioner's office.
What is Drew Taylor's background?
A PhD in biomedical engineering from the University of Toronto plus a BSc and MSc from the University of Michigan. He discovered the potential of hair-follicle stem cells during his doctoral research and founded Acorn in 2017.